Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
life sciences
national blog main
rna interference
alexion pharmaceuticals
alirocumab
alnylam pharmaceutials
alnylam pharmaceuticals
amgen
arrowhead pharmaceuticals
boehringer ingelheim
boston
boston top stories
deals
dicerna pharmaceuticals
drugs
eli lilly
evercore isi
evolocumab
heart attack
hepatitis b
inclisiran
indiana blog main
indiana top stories
johnson & johnson
joseph swartz
medicines co.
national top stories
neurodegenerative diseases
new york
new york blog main
new york top stories
pcsk9 inhibitors
primary hyperoxaluria
regeneron pharmaceuticals
san francisco blog main
san francisco top stories
stroke
What
long
2
×
medicines
rna
2
×
abandoning
ago
alnylam
baggage
based
cholesterol
companies
cuts
data
deal
development
dicerna
drug
evidence
free
gets
heart
interference
lasting
looms
lowering
medco
new
partner
pharma
pharmaceuticals
presented
reckoning
rnai
signs
small
supporting
term
touts
use
wasn’t
Language
Current search:
rna
×
long
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M